Mode
Text Size
Log in / Sign up

Gastrointestinal complications in cardiac surgery patients are linked to high mortality and multiorgan failure.

Gastrointestinal complications in cardiac surgery patients are linked to high mortality and multiorg…
Photo by Aakash Dhage / Unsplash
Key Takeaway
Note that GI complications in cardiac surgery patients are associated with high mortality and multiorgan failure.

This retrospective case–control study evaluated patients undergoing cardiac surgery to assess the impact of gastrointestinal complications. The initial cohort included 8,544 patients, which was reduced to 162 patients after matching, comprising 54 in the gastrointestinal complication group and 108 controls. The study focused on gastrointestinal complications defined as bleeding, ischemia/perforation, obstruction, or pancreatitis.

The analysis revealed that smokers were more frequent in the gastrointestinal complication group versus controls (p = 0.0049). Similarly, patients with significant coronary artery disease were more frequent in the gastrointestinal complication group versus controls (p = 0.0013). The composition of gastrointestinal complications consisted of ischemia (50.6%), hemorrhage (31.5%), pancreatitis (3.7%), and obstruction (14.8%).

Outcomes showed that multiorgan failure occurred in 24.1% of cases within the gastrointestinal complication group. Overall mortality was markedly higher in the gastrointestinal complication group compared to controls, at 38.8% versus 0.9% (p < 0.0001). A risk score demonstrated an area under the curve of 0.735 (95% CI 0.653–0.816), with a Hosmer–Lemeshow test p-value of 0.934 indicating calibration.

The study underscores the importance of close monitoring and timely intervention in this population. However, because the evidence is observational, causal language is avoided. Safety data, discontinuations, and tolerability were not reported. The study phase and publication type were not reported. These limitations suggest that while the association is strong, clinical application should be restrained until further evidence is available.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
IntroductionGastrointestinal (GI) complications after cardiac surgery, although uncommon (0.4–3%), are associated with high mortality rates (13–63%). This study aimed to describes outcomes of GI complications and propose a risk score predicting their occurrence.MethodsWe conducted a retrospective case–control study including 8,544 patients undergoing cardiac surgery between 2005 and 2019. GI complications—defined as bleeding, ischemia/perforation, obstruction, or pancreatitis—were used to select cases for 1:2 propensity score matching with controls. Multivariable logistic regression was performed to determine independent predictors of a composite endpoint (postoperative pulmonary, renal, and cardiac complications). A GI complication risk score was then developed.ResultsAfter matching, 162 patients were analyzed (54 GI group, 108 controls). Smokers and patients with significant coronary artery disease were more frequent in the GI group (p = 0.0049 and p = 0.0013). GI complications included ischemia (50.6%), hemorrhage (31.5%), pancreatitis (3.7%), and obstruction (14.8%), with 24.1% occurring as part of multiorgan failure. Overall mortality in the GI group was 38.8% compared with 0.9% in controls (p 2, and preoperative acute myocardial ischemia. The risk score, incorporating smoking, age, chronic kidney disease, and mitral valve replacement, showed good discrimination (area under the curve 0.735, 95% CI 0.653–0.816) and calibration (Hosmer–Lemeshow p = 0.934).ConclusionsMortality remains high among patients who develop GI complications after cardiac surgery, regardless of treatment modality. This risk score represents a potentially valuable tool for identifying patients at increased risk and underscores the importance of close monitoring and timely intervention in this population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.